BRAF Mutant Lung Cancer: Programmed Death Ligand 1 Expression, Tumor Mutational Burden, Microsatellite Instability Status, and Response to Immune Check-Point Inhibitors

Elizabeth Dudnik(Rabin Medical Center), Nir Peled(Ben-Gurion University of the Negev), Hovav Nechushtan(Hadassah Medical Center), Mira Wollner(Technion – Israel Institute of Technology), Amir Onn(Tel Aviv University), Abed Agbarya(Bnai Zion Medical Center), Mor Moskovitz(Rambam Health Care Campus), S. Keren(Carmel Medical Center), Noa Popovits‐Hadari(Carmel Medical Center), Damien Urban(Sheba Medical Center), Moshe Mishaeli(Meir Medical Center), Alona Zer(Rabin Medical Center), Aaron M. Allen(Tel Aviv University), Natalie Maimon Rabinovich(Meir Medical Center), Ofer Rotem(Rabin Medical Center), Teodor Kuznetsov(Sheba Medical Center), Tzippy Shochat(Rabin Medical Center), Laila C. Roisman(Soroka Medical Center), Jair Bar(Tel Aviv University)
Journal of Thoracic Oncology
April 30, 2018
Cited by 220Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis